Lantus

Lantus (insulin glargine U-100) is one of the most widely prescribed long-acting basal insulins in the world. First approved in 2000, it revolutionized basal insulin therapy by offering a near-peakless 24-hour glucose-lowering profile, allowing once-daily dosing for most patients. It is available as the Lantus SoloStar prefilled pen and as 10 mL vials, and treats both type 1 and type 2 diabetes in adults and children 6 and older.

Lantus belongs to the Long-Acting Insulin Analogs class. After subcutaneous injection it forms microprecipitates that release insulin slowly over approximately 24 hours, providing a flat basal profile that closely mimics endogenous insulin secretion during fasting. The dose is highly individualized.

## What Lantus is used for

Lantus is indicated for glycemic control in type 1 diabetes (typically combined with a mealtime rapid-acting insulin in a basal-bolus regimen) and type 2 diabetes (alone, or combined with oral hypoglycemics, GLP-1 agonists, or prandial insulin). It is approved for adults and pediatric patients age 6 and older.

## Dosage and how to use the Lantus SoloStar pen

Lantus is injected subcutaneously once daily at the same time each day — most commonly in the evening. Rotate injection sites between the abdomen, thigh, or upper arm.

Typical type 2 starting dose: 10 units once daily or 0.2 units/kg, then titrate by 2–4 units every 3–7 days based on fasting plasma glucose (target typically 80–130 mg/dL).

To use the SoloStar pen: 1. Attach a new pen needle. 2. Perform a 2-unit safety test (priming) until insulin appears. 3. Dial the prescribed dose. 4. Inject SC at a 90° angle and hold for 10 seconds. 5. Remove and dispose of the needle.

Never reuse needles, and never share pens.

## Side effects of Lantus

Common: hypoglycemia, weight gain, injection-site reactions (redness, swelling, itching), and peripheral edema. Serious: severe hypoglycemia (can cause loss of consciousness or seizure), hypokalemia, and allergic reactions. Rare: lipodystrophy with poor injection-site rotation, anaphylaxis.

## Managing common side effects

• Hypoglycemia: carry rapid-acting glucose (tablets, juice). Teach family members glucagon administration.
• Weight gain: continue diet and exercise; consider GLP-1 add-on if appropriate.
• Injection-site reactions: rotate sites and check insulin temperature.
• Lipodystrophy: rotate injection sites systematically across the abdomen and thighs.

## Lantus vs Tresiba, Toujeo, Basaglar, and Levemir

• Lantus vs Tresiba: Tresiba (degludec) lasts ≥42 hr, allows more flexible dosing, and may cause less nocturnal hypoglycemia. Lantus is ~24 hr peakless basal.
• Lantus vs Toujeo: Toujeo is glargine U-300 — more concentrated, longer-acting, and may reduce hypoglycemia risk at higher doses.
• Basaglar vs Lantus: Basaglar is a biosimilar insulin glargine with the same active molecule at lower price. Many patients switch unit-for-unit.
• Levemir vs Lantus: Levemir (detemir) often requires twice-daily dosing for full coverage.
• Semglee and Rezvoglar: Both are interchangeable biosimilars of Lantus.

## Lantus dosing calculator and conversion

When switching between basal insulins: - Lantus → Tresiba: start at the same total daily dose, then adjust based on fasting glucose. - Toujeo → Lantus: start at 80% of the Toujeo dose (less concentrated). - Tresiba → Lantus: start at the same total dose; monitor for hypoglycemia given Tresiba's longer tail.

## Cost, coupons, and assistance

Without insurance, Lantus runs $300–$400 per box of 5 SoloStar pens or per 10 mL vial. The Lantus Savings Card ($0 copay for eligible commercially insured patients), the Sanofi Patient Assistance Program (income-based, free product for qualifying patients), Medicare's $35/month insulin cap, and biosimilars (Basaglar, Semglee, Rezvoglar) all reduce real cost. Search for Lantus coupon $0 co-pay, Lantus savings card, Lantus solostar pen price, or where to buy Lantus insulin cheap for current programs.

## How long does Lantus take to work?

Lantus begins lowering blood glucose 1–4 hours after injection and reaches steady state after 3–4 days of consistent dosing. Its peak effect is intentionally minimal — Lantus is designed for stable basal control, not rapid correction.

## Drug interactions

Combining Lantus with sulfonylureas, meglitinides, or other insulins increases hypoglycemia risk. Beta-blockers may mask hypoglycemia warning symptoms. Pioglitazone plus insulin can cause fluid retention and heart failure. Alcohol potentiates and prolongs hypoglycemia.

## Monitoring and lifestyle

Self-monitoring of blood glucose (or CGM) is essential. Standard monitoring includes HbA1c every 3–6 months, fasting glucose for titration, and periodic kidney function tests. Sick-day rules and adjustments for exercise should be reviewed.

## Storage and travel

Unopened pens or vials: refrigerate at 2–8°C. In-use Lantus may be kept at room temperature (≤25–30°C) for 28 days. Do not freeze. Avoid direct sunlight and car dashboards. For travel, use an insulated case and carry a prescription label or doctor's letter.

## Use in specific populations

Pregnancy: Insulin is the preferred glucose-lowering therapy; consult an endocrinologist. Breastfeeding: Compatible. Children: Approved from age 6. Older adults: Higher hypoglycemia risk — titrate slowly and use simpler regimens when possible.

## Lantus for cats

Veterinarians sometimes use Lantus for feline diabetes due to its glargine-specific characteristic of forming subcutaneous depots. Dosing differs substantially from human protocols — always follow a veterinarian's individualized plan.

## Key takeaways

• Lantus is a long-acting basal insulin with ~24-hour peakless duration.
• Dose once daily at the same time; titrate to fasting glucose target.
• Hypoglycemia is the most common adverse effect; never skip rapid-acting glucose backup.
• Biosimilars (Basaglar, Semglee, Rezvoglar) provide lower-cost interchangeable options.
• Once opened, pens or vials are good at room temperature for 28 days.

## Medical disclaimer

This article about Lantus (insulin glargine) is for general education and is not a substitute for professional medical advice, diagnosis, or treatment. Always follow the guidance of your physician or pharmacist and the instructions on your prescription label.